Cargando…

Investigational drugs with dual activity against HBV and HIV (Review)

Chronic hepatitis B (CHB) and acquired immunodeficiency syndrome (AIDS) are global public health problems that pose a significant health burden. Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection is common, as these viruses have similar transmission routes, such as blood tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Shiyu, Yang, Qing, Sheng, Yunjian, Fu, Yi, Sun, Changfeng, Deng, Cunliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690342/ https://www.ncbi.nlm.nih.gov/pubmed/33262821 http://dx.doi.org/10.3892/etm.2020.9467

Ejemplares similares

Association of toll-like receptor polymorphisms with acquisition of HIV infection and clinical findings: A protocol for systematic review and meta-analysis
por: Shi, Han, et al.
Publicado: (2020)

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
por: Luo, Meiyan, et al.
Publicado: (2021)

Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis
por: Shi, Han, et al.
Publicado: (2019)

AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics
por: Liu, Xiaoling, et al.
Publicado: (2021)

THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
por: Ding, Yuxi, et al.
Publicado: (2022)

A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study
por: Qiang, Li, et al.
Publicado: (2020)

Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Li, Qin, et al.
Publicado: (2018)

Theoretical Investigation on the ESIPT Process and Detection Mechanism for Dual-Proton Type Fluorescent Probe
por: Cao, Yunjian, et al.
Publicado: (2022)

HEV and HBV Dual Infection: A Review
por: Nasir, Myra, et al.
Publicado: (2020)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance
por: Meng, Chao-Yang, et al.
Publicado: (2023)

Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon
por: Bivigou-Mboumba, Berthold, et al.
Publicado: (2016)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective
por: Nie, Yuan, et al.
Publicado: (2020)

The dual functions of KDM7A in HBV replication and immune microenvironment
por: Yang, Di, et al.
Publicado: (2023)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system
por: Wu, Kailang, et al.
Publicado: (2007)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
por: Lee, Z., et al.
Publicado: (2015)

Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia
por: Belyhun, Yeshambel, et al.
Publicado: (2018)

A type-specific nested PCR assay established and applied for investigation of HBV genotype and subgenotype in Chinese patients with chronic HBV infection
por: Nie, Jing-Jing, et al.
Publicado: (2012)

Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
por: Hua, Wenhao, et al.
Publicado: (2015)

Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs
por: Li, Feng, et al.
Publicado: (2016)

HIV, HCV and HBV: A Review of Parallels and Differences
por: Leoni, Maria C., et al.
Publicado: (2018)

Prevalence and Genotyping of Torque Teno Virus in HBV/HIV and Chronic HBV Patients in Iran
por: Najafimemar, Zahra, et al.
Publicado: (2018)

Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region
por: Zhou, Yan-Heng, et al.
Publicado: (2011)

Multiomics Analysis of Endocytosis upon HBV Infection and Identification of SCAMP1 as a Novel Host Restriction Factor against HBV Replication
por: Yousaf, Tanzeel, et al.
Publicado: (2022)

Anti-HBV Drugs: Progress, Unmet Needs, and New Hope
por: Kang, Lei, et al.
Publicado: (2015)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan
por: Sharif, M., et al.
Publicado: (2009)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Pre-S Deletions are Predominant Quasispecies in HIV/HBV Infection: Quasispecies Perspective
por: Nie, Yuan, et al.
Publicado: (2020)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
por: Puglia, Monia, et al.
Publicado: (2015)

HBV Infection in HIV-Driven Immune Suppression
por: Sarmati, Loredana, et al.
Publicado: (2019)

NKG2C(+) natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV
por: Song, Ting, et al.
Publicado: (2020)

The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive
por: Guo, Yan, et al.
Publicado: (2022)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gu0s1olcuaab4rl89o87e4qbnl